• About
  • Subscribe
  • Advertise
  • Contact
Monday, June 23, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Business

Patient information or advertising?

by Staff Writer
March 2, 2021
in Business, Practice management
Reading Time: 4 mins read
A A
Patient stories and testimonials can be a contentious area for practices.

Patient stories and testimonials can be a contentious area for practices.

Share on FacebookShare on Twitter

The regulator has announced an audit of health practitioner advertising that affects eyecare professionals. Avant’s RUANNE BRELL and DR VICKY PHAN outline what’s acceptable and what to avoid.

How do you communicate with patients about your practice and services? Like other aspects of running a business at present, that seems increasingly complicated.

Some practices now produce information videos to help patients understand what particular treatments involve. Can you also post these on your website and social channels? Could that be seen as advertising?

Ruanne Brell.

In our experience, most healthcare professionals recognise the need for responsible advertising that won’t compromise the public’s healthcare choices. However, as healthcare businesses explore more ways to communicate with patients online, understanding what exactly is advertising under the National Law and when the rules apply is increasingly complex.

The Australian Health Practitioner Regulation Agency (AHPRA) has progressively added to its guidance on advertising regulated health services. Its updated Guidelines for advertising a regulated health service (2020 Guidelines) came into effect on 14 December 2020 and help clarify some of these nuanced issues.

Have the rules changed?

The 2020 Guidelines don’t substantively change the requirements for advertising regulated health services.

They provide further explanation and examples of the way AHPRA interprets these obligations and what it considers advertising. We focus on sections 3, 4.1, 4.4 and the Definitions section of the 2020 Guidelines.

When is content advertising? 

Content could be described as something other than an advertisement: advertorial, branded content, content marketing. It may be verbal, printed or electronic.

Vicky Phan.

As the boundaries increasingly blur between advertising, education and information, AHPRA is focusing on the intention and effect of communications. Any communication may be considered advertising if it promotes and seeks to attract a person to a regulated health service provider and/or attract a person to use the regulated health service.

Social media content could also be considered advertising. As could podcasts, public speaking engagements, books, media appearances, patient information sheets, patient recalls or other professional notices, office signage or mobile communications.

A patient information video explaining treatment or costs isn’t considered advertising if it’s provided in the context of a consultation where the patient has adequate opportunity to discuss the information and ask questions. However, the 2020 Guidelines warn against including material that could be interpreted as promoting the practitioner’s services.

Additionally, not all services provided by a healthcare business may be regulated health services. Products such as medicines or medical devices are not covered by the National Law but fall under different schemes including the Australian Consumer Law and Therapeutic Goods Act and associated regulations.

Many of the same principles apply, for example misleading and deceptive conduct would be prohibited under these regimes as well. If notified, AHPRA would refer complaints about these aspects of a healthcare business to the appropriate regulator, and the specific prohibitions and penalties differ.

What can you say?

Importantly, advertising regulated health services is permitted. AHPRA acknowledges advertising can be helpful and effective. You can still produce content AHPRA considers advertising, as long as it complies with the advertising requirements under the National Law.

The 2020 Guidelines include examples and decision trees to help clarify what is and isn’t permitted. Advertisements could breach the National Law if, for example, they:

  • Create an unreasonable expectation of outcomes or recovery time.
  • Overstate the potential benefit, or
  • Minimise the complexity or risk.

Be particularly careful to avoid:

  • Claims your health service is superior.
  • Claims about the effectiveness of a particular treatment or suggesting it can ‘cure’ a condition.
  • Suggesting treatments are ‘safe’, ‘effective’, ‘painless’, ‘infallible’.
  • Implying the practitioner has an exclusive or unique skill, or a particular qualification that they do not hold.
  • Patient stories or images that may create an unreasonable expectation of benefit. Any claims about effectiveness need to be backed by acceptable evidence, and the guidelines also explain what sort of evidence would be acceptable.

In the case of an agency or third party publishing material, AHPRA considers you the advertiser if you publish or authorise content, direct someone else to draft or publish it, or if you are able to remove it.

Ensure anyone creating or publishing content on your behalf understands the advertising restrictions, and that you review content produced as you will be ultimately responsible.

While AHPRA has announced an audit of health practitioner advertising, it reiterates its strategy is to encourage compliance, and any regulatory action will be proportionate to any risk to the public. With this in mind, continue to communicate with patients but understand your obligations and seek advice if in doubt.

ABOUT THE AUTHORS: Ruanne Brell is a senior solicitor of the Medico Legal Advisory Service at Avant, and Dr Vicky Phan is a GP and Avant risk adviser.

More reading

AHPRA announces advertising audit affecting optometrists

The perils of treating friends and family

Is your healthcare advertising compliant?

Tags: 2020 GuidelinesadvertisingAHPRAAustraliaAustralian Health Practitioner Regulation AgencyAvantGuidelines for advertising a regulated health serviceophthalmologyoptometristregulationRuanne BrellVicky Pham

Related Posts

Image: Kzenon/Shutterstock.com.

Special report: Tweaks optometry businesses can make in testing times

by Myles Hume
June 16, 2025

With reports cost-of-living pressures are influencing health decisions, patients are demanding more from their eyecare professional. Insight investigates how optometrists...

Lens waste is prepared as part of the recycling process.

Partnership gives HOYA an environmental edge

by Rob Mitchell
June 15, 2025

HOYA has made a significant step in achieving its environmental goals. Its leaders say it was a relatively easy foot...

The team at Eyecare Plus Optometrists Moss Vale (from left), Jocelyn Doyle, Lara Foster, Cindy Wilson, and Alex Swane. Images: Eyecare Plus.

Eyecare Plus network – when more heads are better than one

by Rob Mitchell
June 14, 2025

Two independent optometry practice owners explain how being part of a large national network can actually enhance the individuality and...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited